Chronos Archive seal
The Human Record

Barbara Jordan

Case HR-ML030-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
February 21, 1936 – January 17, 1996
Synthetic DOB
1936-02-21
Index visit
1980-03-02 at age 44
Synthetic MRN
HR-ML030-SYN-TD

Teaching objective: Primary care, coordinated with a multiple sclerosis neurologist, for a 44-year-old professor and public speaker who walks with a cane and has multiple sclerosis diagnosed elsewhere: confirming and classifying the disease with MRI of the brain and spine under the 1971 McDonald criteria and the 1975 MAGNIMS-CMSC-NAIMS consensus, choosing a disease-modifying therapy by course and risk under the AAN 1972 guideline, the screening and vaccination it needs before the first dose (hepatitis B serology, immunoglobulins, liver tests, blood counts, varicella and measles immunity, tuberculosis, inactivated vaccines at least two weeks ahead), its monitoring afterwards, a re-baseline MRI, recognizing relapse and pseudo-relapse, symptom care for spasticity, bladder, fatigue and heat sensitivity, mobility equipment and fall prevention, a workplace accommodation that discloses only what she chooses, bone health, mood screening, and preventive care, respecting her wish to keep her diagnosis private.

Historical timeline

DateEventClaims
February 21, 1936Born in Houston, Texas.CLM-0001
1959Law degree from Boston University.CLM-0001
1966Elected to the Texas Senate.CLM-0002
November 1972Elected to the U.S. House of Representatives.CLM-0002
1974House Judiciary Committee impeachment hearings.CLM-0002
1976Keynote address at the Democratic National Convention.CLM-0003
1978Walking with a cane in her last House years, attributed at the time to a knee problem.CLM-0005
1979Left the House; became a professor at the LBJ School of Public Affairs; multiple sclerosis diagnosed around this time, as later revealed.CLM-0004, CLM-0006
1988Spoke from a wheelchair at the Democratic National Convention.CLM-0007, CLM-0008
1992Convention keynote address from a wheelchair.CLM-0007
1994Presidential Medal of Freedom.CLM-0009
January 17, 1996Died in Austin at 59.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Barbara Jordan was born on February 21, 1936, in Houston, Texas, the youngest of three daughters, and grew up in Houston's Fifth Ward. She graduated magna cum laude from Texas Southern University in 1956 and earned a law degree from Boston University in 1959. confirmed Jordan, Barbara Charline (Handbook of Texas Online) supports
Barbara Charline Jordan supports
HISTMED Master Roster v3 context
D In 1966 she was elected to the Texas Senate, the first Black state senator since 1883. In 1972 she was elected to the U.S. House of Representatives from Houston, the first Black woman from a Southern state to serve in Congress. As a member of the House Judiciary Committee during the 1974 impeachment hearings she said, "My faith in the Constitution is whole, it is complete, it is total." confirmed Jordan, Barbara Charline (Handbook of Texas Online) supports
JORDAN, Barbara Charline (Biographical Directory and Black Americans in Congress profile) supports
Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) supports
D In 1976 she gave the keynote address at the Democratic National Convention, the first woman and the first African American to do so.
Anchors her public speaking in the modern social history.
confirmed Jordan, Barbara Charline (Handbook of Texas Online) supports
Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) supports
D She did not seek a fourth term and left the House in 1979, downplaying reports about her poor health and citing her "internal compass." She became the Lyndon Baines Johnson Public Service Professor at the LBJ School of Public Affairs of the University of Texas at Austin, where she taught until the early 1990s.
Anchors the modern episode in her work as a professor and public speaker in Austin, and the reports of poor health at the time she left Congress.
confirmed Jordan, Barbara Charline (Handbook of Texas Online) supports
JORDAN, Barbara Charline (Biographical Directory and Black Americans in Congress profile) supports
Barbara Jordan, 1936-1996: A Powerful Voice for Justice and Social Change (People in America) supports
D In her later years in the House she walked with a cane, which she attributed at the time to "a bum knee"; a disability-press account written after her death says this was the first adaptive equipment her multiple sclerosis required, and that she did not openly acknowledge the disease for years.
The anchor for the modern episode, which begins about a year after she left the House, with a spastic gait and a cane. The account is a single posthumous article that reports her own public explanation at the time; it is graded probable.
probable Cooper-Dowda R. Barbara Jordan: Hiding in Plain Sight While Working for 'The Common Good' supports
D It was later revealed that she had been diagnosed with multiple sclerosis around the time she left Congress. The year of the diagnosis is not stated in the obituaries and reference works consulted.
Anchors the modern problem of multiple sclerosis diagnosed elsewhere before the index visit. Its timing is uncertain (see CLM-0008).
probable Barbara Jordan supports
Barbara Jordan, 1936-1996: A Powerful Voice for Justice and Social Change (People in America) supports
D She spoke from a wheelchair at the Democratic National Convention in 1988, and in 1992 she gave a second convention keynote address from a wheelchair, amid a lengthy battle with multiple sclerosis.
History after the modern episode; used only as context for the mobility planning.
confirmed JORDAN, Barbara Charline (Biographical Directory and Black Americans in Congress profile) supports
Barbara Jordan, 1936-1996: A Powerful Voice for Justice and Social Change (People in America) supports
Lunardini CA. Jordan, Barbara (Encyclopedia of African-American Culture and History) supports
D Accounts differ on when her multiple sclerosis became public. A broadcaster's profile says it was announced after she left Congress; a disability-press article says her doctors made it public only after she nearly drowned in her pool during physical therapy, which it dates to 1994 (the Texas State Historical Association dates the near-drowning to 1988 and does not link it to the disease); a reference work says her obituaries explained much she had kept private, confirming the multiple sclerosis. Her obituaries reported that she had battled multiple sclerosis for several years and moved about in a wheelchair or with a walker.
Recorded as history; the modern episode does not depend on the date of disclosure, but respects her privacy about her health.
disputed Barbara Jordan, 1936-1996: A Powerful Voice for Justice and Social Change (People in America) supports
Cooper-Dowda R. Barbara Jordan: Hiding in Plain Sight While Working for 'The Common Good' supports
Jordan, Barbara Charline (Handbook of Texas Online) context
Lunardini CA. Jordan, Barbara (Encyclopedia of African-American Culture and History) supports
Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) supports
D She received the Presidential Medal of Freedom in 1994. confirmed Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) supports
D She died in Austin on January 17, 1996, at 59, of pneumonia as a complication of leukemia, and is buried in the Texas State Cemetery.
History only, long after the modern episode; not used in it.
confirmed Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) supports
Jordan, Barbara Charline (Handbook of Texas Online) supports
JORDAN, Barbara Charline (Biographical Directory and Black Americans in Congress profile) supports
Barbara Charline Jordan supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Multiple sclerosis diagnosed elsewhere, by her account, with records of the original evaluation not available: slowly worsening walking over the past few years, leg stiffness, fatigue, urinary urgency and heat sensitivity; uses a cane; course to be classified after MRI of the brain and spine resolved confirmed active CLM-0005, CLM-0006
S Active primary progressive multiple sclerosis: gradual worsening of walking over more than a year without relapses, with brain lesions in periventricular, juxtacortical and infratentorial regions, three spinal cord lesions, and one gadolinium-enhancing lesion; fulfils the 1971 McDonald criteria for primary progressive disease; EDSS 6.0; synthetic modern detail linked to her publicly reported multiple sclerosis active confirmed both_with_link CLM-0005, CLM-0006
S Spastic gait from multiple sclerosis, walking with a cane, with two near-falls and no falls in the past year; at risk of falls active confirmed active CLM-0005
S Neurogenic bladder from multiple sclerosis: urgency and getting up twice at night, with a low post-void residual active confirmed active
S Vitamin D deficiency active confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1980-03-02 Leukocytes [#/volume] in Blood by Automated count 6.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1980-03-02 Lymphocytes [#/volume] in Blood by Automated count 1.9 10*3/uL
Reference 1-4.8 10*3/uL
http://loinc.org · 731-0
S 1980-03-02 Hemoglobin [Mass/volume] in Blood 13.2 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1980-03-02 Platelets [#/volume] in Blood by Automated count 262 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1980-03-02 Creatinine [Mass/volume] in Serum or Plasma 0.78 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1980-03-02 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1975)/1.73 sq M 96 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1980-03-02 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1980-03-02 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 1980-03-02 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 72 U/L
Reference 35-105 U/L
http://loinc.org · 6768-6
S 1980-03-02 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.2-1.2 mg/dL
http://loinc.org · 1975-2
S 1980-03-02 Thyrotropin [Units/volume] in Serum or Plasma 1.8 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 1980-03-02 Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 520 pg/mL
Reference 232-1245 pg/mL
http://loinc.org · 2132-9
S 1980-03-02 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 17 ng/mL (low)
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 1980-03-02 IgG [Mass/volume] in Serum or Plasma 1080 mg/dL
Reference 700-1600 mg/dL
http://loinc.org · 2465-3
S 1980-03-02 IgM [Mass/volume] in Serum or Plasma 110 mg/dL
Reference 40-230 mg/dL
http://loinc.org · 2472-9
S 1980-03-02 IgA [Mass/volume] in Serum or Plasma 210 mg/dL
Reference 70-400 mg/dL
http://loinc.org · 2458-8
S 1980-03-02 JC virus Ab Index in Serum or Plasma by Immunoassay 0.14
Reference Below 0.20 negative; 0.20 to 0.40 indeterminate; above 0.40 positive
http://loinc.org · 100977-8
S 1980-03-02 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1980-06-29 Leukocytes [#/volume] in Blood by Automated count 5.9 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1980-06-29 Lymphocytes [#/volume] in Blood by Automated count 1.4 10*3/uL
Reference 1-4.8 10*3/uL
http://loinc.org · 731-0
S 1980-06-29 Hemoglobin [Mass/volume] in Blood 13.4 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1980-06-29 Platelets [#/volume] in Blood by Automated count 248 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1980-06-29 CD19 cells [#/volume] in Blood 3 /uL (low)
Reference Expected to be depleted after an anti-CD20 therapy
http://loinc.org · 8116-6
S 1980-06-29 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1980-06-29 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 ng/mL
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 1980-06-29 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 1980-08-17 Hemoglobin A1c/Hemoglobin.total in Blood 5.4%
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes
http://loinc.org · 4548-4
S 1980-08-17 Cholesterol [Mass/volume] in Serum or Plasma 186 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1980-08-17 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 110 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 1980-08-17 Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 1980-08-17 Triglyceride [Mass/volume] in Serum or Plasma 98 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1980-10-26 Leukocytes [#/volume] in Blood by Automated count 6.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1980-10-26 Lymphocytes [#/volume] in Blood by Automated count 1.5 10*3/uL
Reference 1-4.8 10*3/uL
http://loinc.org · 731-0
S 1980-10-26 Hemoglobin [Mass/volume] in Blood 13.5 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1980-10-26 Platelets [#/volume] in Blood by Automated count 255 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1980-10-26 IgG [Mass/volume] in Serum or Plasma 1010 mg/dL
Reference 700-1600 mg/dL
http://loinc.org · 2465-3
S 1980-10-26 IgM [Mass/volume] in Serum or Plasma 72 mg/dL
Reference 40-230 mg/dL
http://loinc.org · 2472-9
S 1980-10-26 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1980-10-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1975)/1.73 sq M 93 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1980-10-26 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1980-10-26 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 1980-08-17 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7

Synthetic vital signs

DateMeasureResultLOINCGrade
1980-03-02Body height173 cm8302-2S
1980-03-02Body weight84 kg29463-7S
1980-03-02Body mass index (BMI) [Ratio]28.1 kg/m239156-5S
1980-03-02Systolic blood pressure124 mm[Hg]8480-6S
1980-03-02Diastolic blood pressure78 mm[Hg]8462-4S
1980-03-02Heart rate76 /min8867-4S
1980-03-02Respiratory rate16 /min9279-1S
1980-03-02Body temperature36.7 Cel8310-5S
1980-03-02Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1980-03-16Body height173 cm8302-2S
1980-03-16Body weight84.2 kg29463-7S
1980-03-16Body mass index (BMI) [Ratio]28.1 kg/m239156-5S
1980-03-16Systolic blood pressure122 mm[Hg]8480-6S
1980-03-16Diastolic blood pressure76 mm[Hg]8462-4S
1980-03-16Heart rate74 /min8867-4S
1980-03-16Respiratory rate16 /min9279-1S
1980-03-16Body temperature36.6 Cel8310-5S
1980-03-16Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1980-04-20Body height173 cm8302-2S
1980-04-20Body weight83.8 kg29463-7S
1980-04-20Body mass index (BMI) [Ratio]28 kg/m239156-5S
1980-04-20Systolic blood pressure120 mm[Hg]8480-6S
1980-04-20Diastolic blood pressure76 mm[Hg]8462-4S
1980-04-20Heart rate72 /min8867-4S
1980-04-20Respiratory rate16 /min9279-1S
1980-04-20Body temperature36.6 Cel8310-5S
1980-04-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1980-06-29Body height173 cm8302-2S
1980-06-29Body weight83.5 kg29463-7S
1980-06-29Body mass index (BMI) [Ratio]27.9 kg/m239156-5S
1980-06-29Systolic blood pressure118 mm[Hg]8480-6S
1980-06-29Diastolic blood pressure74 mm[Hg]8462-4S
1980-06-29Heart rate74 /min8867-4S
1980-06-29Respiratory rate16 /min9279-1S
1980-06-29Body temperature36.8 Cel8310-5S
1980-06-29Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1980-10-26Body height173 cm8302-2S
1980-10-26Body weight83.2 kg29463-7S
1980-10-26Body mass index (BMI) [Ratio]27.8 kg/m239156-5S
1980-10-26Systolic blood pressure120 mm[Hg]8480-6S
1980-10-26Diastolic blood pressure76 mm[Hg]8462-4S
1980-10-26Heart rate72 /min8867-4S
1980-10-26Respiratory rate16 /min9279-1S
1980-10-26Body temperature36.6 Cel8310-5S
1980-10-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1980-08-17Body height173 cm8302-2S
1980-08-17Body weight83.4 kg29463-7S
1980-08-17Body mass index (BMI) [Ratio]27.9 kg/m239156-5S
1980-08-17Systolic blood pressure118 mm[Hg]8480-6S
1980-08-17Diastolic blood pressure74 mm[Hg]8462-4S
1980-08-17Heart rate74 /min8867-4S
1980-08-17Respiratory rate16 /min9279-1S
1980-08-17Body temperature36.7 Cel8310-5S
1980-08-17Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Diagnosis confirmed and classified, vaccines completed at least two weeks before therapy, and a disease-modifying therapy started within ten weeks1980-06-29completedPrimary progressive disease confirmed at two weeks; vaccines finished at five weeks; ocrelizumab started at nine weeks
No falls through eight months1980-10-26completedNo falls; one near-fall in the summer heat
25-hydroxyvitamin D at least 30 ng/mL within four months1980-06-29completed34 ng/mL at four months
Up no more than once a night to pass urine within three months1980-06-29completedOnce a night or less on mirabegron
Keep her full teaching and speaking schedule with the accommodations she chooses1980-10-26completedFull schedule kept; accessible rooms, seating and parking in place
No new or enlarging T2 lesions on the re-baseline MRI1980-10-26completedNo new or enlarging T2 lesions

Interventions

InterventionStatusGuideline
Confirm and classify the diagnosis: MRI of the brain and the cervical and thoracic spine with gadolinium to the MAGNIMS-CMSC-NAIMS protocol, read against the 1971 McDonald criteria; exclude mimics with vitamin B12, TSH and HIV; request the records of the original evaluationcompletedGL-MCDONALD-2017, GL-MAGNIMS-2021
Neurology (multiple sclerosis) consultation to confirm and classify the disease and advise on disease-modifying therapy, its monitoring, vaccination, symptom care and MRI follow-upcompletedGL-AAN-DMT-2018, GL-MCDONALD-2017, GL-MAGNIMS-2021
Screening before any disease-modifying therapy: hepatitis B surface antigen, core antibody and surface antibody; quantitative immunoglobulins; liver tests; blood count with lymphocytes; varicella and measles immunity; tuberculosis blood test; HIV and hepatitis C; JC virus antibody; and vaccines brought up to date, inactivated vaccines at least two weeks and live vaccines at least four weeks before the first dosecompletedGL-AAN-DMT-2018, GL-AAN-VAX-2019, GL-CDC-IMZ-2026
Relapse and pseudo-relapse plan: new or worsening symptoms lasting more than 24 hours without fever or heat mean a same-day call; check for urinary infection and fever first, because infection and heat can bring back old symptoms; written card for her bagcompletedGL-AAN-DMT-2018, GL-NICE-MS-2022
Mobility, spasticity and falls: physical therapy evaluation for gait, strengthening, stretching, balance and a home exercise program; review of walking aids, with forearm crutches or a rollator and a scooter for long distances when she wants them; home safety review; daily stretchingcompletedGL-NICE-MS-2022, GL-CMID-2026
Bladder: post-void residual today, timed voiding, fluids earlier in the day, less caffeine, pelvic floor exercises, and a medicine if urgency persists; urine check for any burning, fever or sudden worseningcompletedGL-NICE-MS-2022
Fatigue and heat sensitivity: energy conservation and pacing with an occupational therapy review, teaching sessions placed in the morning where she chooses, cooling garments, air conditioning, cool drinks, and aerobic exercise such as pool exercise in cool watercompletedGL-NICE-MS-2022
Work: a letter to her employer, with her consent, describing her functional needs (an accessible teaching room near an elevator, a chair and lectern for lectures, reserved parking near her building, and flexibility for medical appointments) without naming the diagnosis; she decides what to disclosecompletedGL-JAN-MS, GL-ADA
Bone health: vitamin D3 with a recheck, calcium from food, weight-bearing exercise, fall prevention, and bone density at the preventive visit because of reduced mobility and earlier steroid coursescompletedGL-CMID-2026, GL-NICE-MS-2022
Mood and cognition: PHQ-9 at intake and every six months; ask about concentration and word-finding; counseling offered at any timecompletedGL-USPSTF-DEP-2023, GL-NICE-MS-2022, GL-CMID-2026
On the consultant's advice: ocrelizumab 300 mg on day 1 and day 15 and then 600 mg every 6 months, after the vaccines and at least two weeks after the last inactivated dose, with premedication and observation; blood count and immunoglobulins before each dose; a re-baseline brain MRI three to six months after the first dose and then yearly; baclofen titrated to 10 mg three times a day; mirabegron with a blood pressure check at each visitcompletedGL-AAN-DMT-2018, GL-OCR-LABEL, GL-MAGNIMS-2021, GL-NICE-MS-2022

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Jordan, Barbara Charline (Handbook of Texas Online) Texas State Historical Association biography
SRC-0002 JORDAN, Barbara Charline (Biographical Directory and Black Americans in Congress profile) U.S. House of Representatives, History, Art & Archives government
SRC-0003 Boyer EJ. Barbara Jordan, voice of conscience, dead at 59 (Los Angeles Times) The Spokesman-Review other
SRC-0004 Barbara Jordan, 1936-1996: A Powerful Voice for Justice and Social Change (People in America) Voice of America Learning English other
SRC-0005 Lunardini CA. Jordan, Barbara (Encyclopedia of African-American Culture and History) Encyclopedia.com biography
SRC-0006 Cooper-Dowda R. Barbara Jordan: Hiding in Plain Sight While Working for 'The Common Good' Ragged Edge Magazine other
SRC-0007 Barbara Jordan Biography.com biography
SRC-0008 Barbara Charline Jordan Texas State Cemetery government
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the McDonald classification as active primary progressive disease, the ocrelizumab choice and its screening, the vaccine timing, the re-baseline MRI without gadolinium, baclofen and mirabegron, and the decision to obtain bone density at 44.
provenance reviewnot_startedRecent-death rule: only what was reported in her life or in obituaries and reference works: the Texas State Historical Association, the House history, the Los Angeles Times obituary, a broadcaster's profile, an encyclopedia entry, a biography site, the State Cemetery and one disability-press article. The diagnosis year and the date of disclosure are uncertain and recorded as such.
safe messaging reviewnot_startedNo mental health or substance claims are made; mood screening is synthetic and below the threshold for a safety assessment. Her death is recorded in one claim as history. Disability is described without pity language, and her privacy about the diagnosis is respected in the modern plan.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.